COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes
Frontiers in Medicine · 22.04.2024 · 11
DOI: 10.3389/fmed.2024.1346646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 22.04.2024. Verfasst von Kunapa Iam-Arunthai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to evaluate the relationship between high-sensitivity C-reactive protein (hsCRP) in hospitalized COVID-19 patients and their clinical outcomes, including trajectory of hsCRP changes during hospitalization. Method and results Patients with positive COVID-19 tests between 2021 and 2023 were admitted to two hospitals. Among 184 adult patients, approximately half (47.3%) had elevated hsCRP levels upon admission, which defined as exceeding the laboratory-specific upper limit of test (> 5.0 mg/L). Clinical outcomes included critical illness, acute kidney injury, thrombotic events, intensive care unit (ICU) requirement, and death during hospitalization. Elevated hsCRP levels had a higher risk of ICU requirement than those with normal, 39.1% versus 16.5%; adjusted odds ratio (aOR), 2.3 [95% CI, 1.05–5.01]; p = 0.036. Patients with extremely high (≥2 times) hsCRP levels had aOR, 2.65 [95% CI, 1.09–6.45]; p < 0.001. On the fifth day hospitalization, patients with high hsCRP levels associated with acute kidney injury (aOR, 4.13 [95% CI, 1.30–13.08]; p = 0.016), ICU requirement (aOR, 2.67 [95%CI, 1.02–6.99]; p = 0.044), or death (aOR, 4.24 [95% CI, 1.38-12.99]; p = 0.011). The likelihood of worse clinical outcomes increased as hsCRP levels rose; patients with elevated hsCRP had lower overall survival rate than those with normal ( p = 0.02). The subset of high hsCRP patients with high viral load also had a shorter half-life compared to those with normal hsCRP level ( p = 0.003).
Conclusion
Elevated hsCRP levels were found to be a significant predictor of ICU requirement, acute kidney injury, or death within 5 days after hospitalization in COVID-19 patients. This emphasized the importance of providing more intensive care management to patients with elevated hsCRP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Division of Infectious Diseases, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.
- Department of Medical Technology and Sciences, International University of Health and Welfare, Okawa, Japan.
Zitieren
APA
Iam-Arunthai, K., Chamnanchanunt, S., Thungthong, P., Chinapha, A., Nakhahes, C., Suwanban, T., & Umemura, T. (2024). COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1346646
Vancouver
Iam-Arunthai K, Chamnanchanunt S, Thungthong P, Chinapha A, Nakhahes C, Suwanban T, et al. COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1346646
BibTeX
@article{IamArunthai2024,
author = {Iam-Arunthai, Kunapa and Chamnanchanunt, Supat and Thungthong, Pravinwan and Chinapha, Anongnart and Nakhahes, Chajchawan and Suwanban, Tawatchai and Umemura, Tsukuru},
title = {COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes},
journal = {Frontiers in Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fmed.2024.1346646}
}
EUVIMED